Dr. Slovick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2316 E Meyer Blvd
Kansas City, MO 64132Phone+1 816-276-4000Fax+1 816-276-3810
Education & Training
- University of Missouri-Kansas City School of MedicineFellowship, Hematology and Medical Oncology, 1984 - 1985
- University of RochesterResidency, Internal Medicine, 1977 - 1981
- Perelman School of Medicine at the University of PennsylvaniaClass of 1977
- University of PennsylvaniaBA, Chemistry, Summa Cum Laude, 1969 - 1973
Certifications & Licensure
- KS State Medical License 1988 - 2025
- MO State Medical License 1984 - 2025
- NY State Medical License 1979 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Awarded a James P. Wilmot Cancer Research Fellowship University of Rochester Cancer Center, 1982
- Awarded the Dr. Spencer Morris Prize in Internal Medicine University of Pennsylvania School of Medicine, 1977
- Alpha Omega Alpha 1976
- Join now to see all
Publications & Presentations
PubMed
- 601 citationsEfficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, James B. Bussel, Roger M. Lyons, Vinod Pullarkat, Terry Gernsheimer
Lancet. 2008-02-02 - Effect of hydrocortisone and interleukins 1 and 2 on eosinophil progenitors in hypereosinophilic statesJane L. Liesveld, Camille N. Abboud, Frank T. Slovick, Jacob M. Rowe, James K. Brennan
International Journal of Cell Cloning. 1988-01-01
Journal Articles
- Efficacy of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura: A Double-blind Randomized Controlled TrialKuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gersheimer TB, SenecalFM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, et.al., Lancet, 1/1/2008
Books/Book Chapters
Abstracts/Posters
- Center Effects on Outcomes in the Treatment of Acute Myelogenous Leukemia (AML): A Multilevel, Community-Based, Case-Controlled StudyFrank Thomas Slovick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Spontaneous Clostridial Myonecrosis in a Man with Drug-induced AgranulocytosisSlovick FT, Bamberger D, Stark KR, Southern Medical Journal, 1/1/1988
- Modulation of Eosinophil Progenitor Growth in Hypereosinophilic StatesSlovick FT, Abboud CN, Rowe JM, Brennan JK, Lichtman MA, Exp Hematology, 1/1/1986
- Join now to see all
Lectures
- Multiple Tumor Board Presentations and DiscussionsNorth Kansas City Hospital - 1/1/2010
- Unknown Primary Cancers-What's New?Providence Medical Center, Kansas City, KS - 1/1/2010
- Adjuvant Therapy for Resected Lung CancerNorth Kansas City Hospital - 1/1/2007
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: